Effect of cationic lipid in cationic liposomes on siRNA delivery into the lung by intravenous injection of cationic lipoplex

Journal of Drug Targeting
Yoshiyuki HattoriHiraku Onishi

Abstract

Cationic liposomes composed of dialkyl cationic lipid such as 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) can efficiently deliver siRNA to the lungs following the intravenous injection of cationic liposome/siRNA complexes (lipoplexes). In this study, we examined the effect of cationic lipid of cationic liposomes on siRNA delivery to the lungs after intravenous injection. We used six kinds of cationic cholesterol derivatives and 11 kinds of dialkyl or trialkyl cationic lipids as cationic lipids, and prepared 17 kinds of cationic liposomes composed of a cationic lipid and 1,2-dioleoyl-L-α-glycero-3-phosphatidylethanolamine (DOPE) for evaluation of siRNA biodistribution and in vivo gene silencing effects. Among cationic liposomes, those composed of N-hexadecyl-N,N-dimethylhexadecan-1-aminium bromide (DC-1-16), N,N-dimethyl-N-octadecyloctadecan-1-aminium bromide (DC-1-18), 2-((1,5-bis(octadecyloxy)-1,5-dioxopentan-2-yl)amino)-N,N,N-trimethyl-2-oxoethan-1-aminium chloride (DC-3-18D), 11-((1,3-bis(dodecanoyloxy)-2-((dodecanoyloxy)methyl)propan-2-yl)amino)-N,N,N-trimethyl-11-oxoundecan-1-aminium bromide (TC-1-12), or cholesteryl (3-((2-hydroxyethyl)amino)propyl)carbamate hydroiodide (HAPC-Chol) with DOPE exhibited high accumulati...Continue Reading

References

Oct 6, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·H IshiwataT Kitagawa
Sep 22, 2001·Matrix Biology : Journal of the International Society for Matrix Biology·S Loughna, T N Sato
Jan 5, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Feng Liu, Leaf Huang
Jul 19, 2003·The Journal of Biological Chemistry·Dmitri SimbergYechezkel Barenholz
Jan 28, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yoshikazu InohMamoru Nakanishi
Sep 27, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yoshiyuki HattoriMitsuru Hashida
Aug 18, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Luc Wasungu, Dick Hoekstra
Oct 3, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Katrien RemautStefaan C De Smedt
Nov 17, 2006·Nature Chemical Biology·David BumcrotDinah W Y Sah
Aug 28, 2007·Journal of the American Chemical Society·Mukthavaram RajeshArabinda Chaudhuri
Dec 25, 2007·International Journal of Pharmaceutics·Wuxiao DingYoshie Maitani
Feb 9, 2008·Human Gene Therapy·Antonin R de Fougerolles
Jun 13, 2008·Nature Protocols·Thomas D Schmittgen, Kenneth J Livak
Sep 12, 2008·Bioorganic & Medicinal Chemistry Letters·Yoshiyuki HattoriYoshie Maitani
Dec 10, 2008·Expert Opinion on Therapeutic Targets·Melanie van der HeijdenA B Johan Groeneveld
Jan 10, 2009·The AAPS Journal·Ramalinga KurubaSong Li
Jan 23, 2009·Nature·Daniela Castanotto, John J Rossi
Apr 7, 2010·Pulmonary Pharmacology & Therapeutics·Birgitt GutbierMartin Witzenrath
Jun 15, 2010·The AAPS Journal·Jie WangJessie L-S Au
Oct 5, 2010·Biochimica Et Biophysica Acta·Christoph StollWillem F Wolkers
Nov 11, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ansgar SantelJörg Kaufmann
Sep 13, 2011·Accounts of Chemical Research·Olivia M Merkel, Thomas Kissel
Dec 24, 2011·International Journal of Clinical Pharmacology and Therapeutics·Dirk StrumbergJoachim Drevs
Jan 3, 2013·International Journal of Pharmaceutics·Yoshiyuki HattoriYoshie Maitani
Jun 6, 2013·Molecular Therapy. Nucleic Acids·Jana McCaskillNigel Aj McMillan
Nov 6, 2013·Biological & Pharmaceutical Bulletin·Naoki YoshikawaKoyo Nishida
Jan 7, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·V FehringJörg Kaufmann
Jun 8, 2014·Advanced Drug Delivery Reviews·Olivia M MerkelThomas Kissel
Oct 8, 2014·International Journal of Pharmaceutics·Yoshiyuki HattoriEtsuo Yonemochi
Dec 30, 2014·Journal of Liposome Research·Yoshiyuki HattoriEtsuo Yonemochi
Mar 7, 2015·Biological & Pharmaceutical Bulletin·Yoshiyuki HattoriEtsuo Yonemochi
Jan 9, 2016·Scientific Reports·Hideyuki MukaiReiko Sugiura
Jun 28, 2016·Journal of Liposome Research·Yoshiyuki HattoriHiraku Onishi

❮ Previous
Next ❯

Citations

Aug 9, 2020·Biochemical Genetics·Olga GawrysElzbieta Kompanowska-Jezierska
Aug 12, 2019·Translational Research : the Journal of Laboratory and Clinical Medicine·Melissa L JagrosseBradley L Nilsson
Jan 29, 2021·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Beatriz Rossi Canuto de MenezesGilmar Patrocínio Thim
Oct 31, 2020·Nucleic Acid Therapeutics·Lidya Salim, Jean-Paul Desaulniers
Feb 19, 2021·Molecular Therapy : the Journal of the American Society of Gene Therapy·Donna KleinVadim Dudkin
Feb 23, 2021·Advanced Healthcare Materials·Zheng-Rong LuNadia Ayat
May 1, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Diedie LiJing Xie
Jul 3, 2021·Pharmaceutics·Maarten K Nijen TwilhaarJoke M M den Haan
Jul 3, 2021·Pharmaceutics·Pavel A Puchkov, Michael A Maslov
Dec 12, 2020·Acta Pharmaceutica Sinica. B·Nitin Bharat CharbeFlavia C Zacconi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.